This is a working overview of visceral adipose tissue, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-06-20. Anything still debated is marked as such rather than presented as settled.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide | GHRH analog family |
| Residue count | 44 amino acids | Matches human GHRH(1-44) backbone |
| N-terminal group | trans-3-hexenoyl | Main structural difference from native hormone |
| Appearance | White to off-white powder | Lyophilized solid form |
| Solubility class | Freely soluble in water | Peptide character; less soluble in organic solvents |
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tedizolid, sold under the brand name Sivextro (by Merck) is an oxazolidinone-class antibiotic. Tedizolid phosphate is a phosphate ester prodrug of the active compound tedizolid. It was developed by Cubist Pharmaceuticals, following acquisition of Trius Therapeutics (originator: Dong-A Pharmaceuticals), and is marketed for the treatment of acute bacterial skin and skin structure infections (also known as complicated skin and skin-structure infections (cSSSIs)). The most common side effects include nausea (feeling sick), headache, diarrhea and vomiting. These side effects were generally of mild or moderate severity. Tedizolid was approved for medical use in the United States in June 2014, and authorized for medical use in the European Union in March 2015. Tedizolid phosphate is a therapeutic alternative on the World Health Organization's List of Essential Medicines.
Manifesting, in addition, that Peru was "a nation without blood, without probity and without sincere inclinations to the ally that had agreed to the alliance "with the deliberate and sole purpose of ensuring its preponderance in the Pacific over Chile." Later, the famous writer from Santa Cruz, René Gabriel Moreno, would come out in defense of Arce for coincidences in his anti-Peruvian positions in Bolivian geopolitics. Referring to Campero, Moreno writes «Is it not well remembered that this man shouted War! War! While he was quietly contemplating the war efforts of his ally Peru?». Like Arce, Moreno is clearly opposed to any understanding or pact with Peru and maintains that Argentina, both the government and the people, were leaning in favor of Bolivia, repudiating, at the same time, Campero's strange and provocative attitude.In Arce's vision, Chile is presented as a vigorous country full of civic virtues that predicted its democratic culture, as well as a Great National Conscience, compared to Peru and Bolivia, weak and in the process of social disintegration due to their lack of modernity. Already in the middle of the War with Chile, Aniceto Arce warned, as the only prospect of peace, an explicit proximity to Chile, turning his back on Peru. The proposal meant breaking the allied front in exchange for the annexation of Tacna and Arica, it meant ultimately betraying the pact made with Peru. Undoubtedly, Aniceto Arce had strong common interests with the British financiers who maintained his headquarters in Chile.
ensure high ethical standards among those working in Human Genetics facilitate communication between those working in Human Genetics provide training and professional recognition for those involved in Human Genetics support professional and lay education about Human Genetics promote public awareness of Human Genetics consider and comment upon matters relevant to Human Genetics or the interests of the Society represent the interests of Human Genetics and those working in the field, and of the Society and its members, in public, professional, governmental and other forums promote and support research in Human Genetics.
=== Biotin === Subsequently, with Vincent du Vigneaud, he used the newly developed technique of chromatography that he had learned while a student in Zürich, to isolate and then crystallize biotin. This work began a theme that continued throughout his career of determining the importance of sulfur in biologically active structures. He applied this to peptides as well.
Sources: en.wikipedia.org
SR-BII (Scavenger Receptor Class B Type II): SR-BII, similar to SR-BI, is involved in lipid transfer and also binds AGEs. It plays a role in mediating the uptake of AGE-modified proteins and helps reduce cellular stress caused by AGEs. By participating in lipid metabolism and AGE clearance, SR-BII contributes to mitigating oxidative damage and supporting cellular homeostasis. DC-SIGN (Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Non-integrin): DC-SIGN is a receptor expressed on dendritic cells and is primarily involved in pathogen recognition and immune responses. Recent research suggests that DC-SIGN can also bind AGEs and mediate their clearance, which helps reduce AGE-induced immune activation. By modulating the immune response to AGEs, DC-SIGN plays a role in maintaining immune homeostasis and preventing chronic inflammation associated with AGE accumulation.
It is not true that more people have died from the COVID-19 vaccine than from COVID-19 itself. Severe adverse reactions from the vaccine are rare, and an "exceedingly small" number of deaths have been caused by the vaccine. Meanwhile, the death toll from the disease itself is in the millions. Tuberculosis is not purely a disease of the lungs that has symptoms of coughing. It may instead infect a wide range of other organs in the body. Cancer cannot be treated by restricting food intake and so supposedly "starving" tumors. Rather, the health of people with cancer is best served by maintaining a healthy diet. The common cold and the common flu are caused by viruses, not exposure to cold temperatures. However, low temperatures may somewhat weaken the immune system, and someone already infected with a cold or influenza virus but showing no symptoms can become symptomatic after they are exposed to low temperatures. Viruses are more likely to spread during the winter for a variety of reasons such as dry air, less air circulation in homes, people spending more time indoors, and lower vitamin D levels in humans. Antibiotics will not cure a cold; they treat bacterial diseases and are ineffectual against viruses. However, they are sometimes prescribed to prevent or treat secondary infections. There is little to no evidence that any illnesses are curable through essential oils or aromatherapy, and fish oil has not been shown to cure dementia.
== Security == A wallet may have known and unknown vulnerabilities. A supply chain attack or side-channel attack are ways of introducing vulnerabilities. In extreme cases a computer which is not connected to any network can be hacked. To mitigate the risk of crypto wallet hacking, one can choose for a cold wallet, which remains offline and disconnected from the internet. A cold wallet refers to a physical device, such as a pen drive, that is utilized as a secure storage medium for transferring money from a hot wallet. Cold wallets have also been hacked. In late July 2026, cold wallet manufacturer Coinkite disclosed that a bug in software used on its devices allowed hackers to access cold wallets. This hack has lead to losses of approximately $130 million as of early August 2026.
Johnson then called a snap election in 2019, where he campaigned on a platform to "Get Brexit Done." The Conservatives won the largest majority in the House of Commons since the 1987 election, leading to the passing of a Brexit deal early in the next decade.
The rate of change of NB, that is dNB/dt, is related to the changes in the amounts of A and B, NB can increase as B is produced from A and decrease as B produces C. Re-writing using the previous results:
Sources: en.wikipedia.org
Monosubstituted products are formed by reacting a large excess of amine with ethylene oxide in presence of water and at a temperature below 100 °C (212 °F). Disubstituted products are obtained with a small excess of ethylene oxide, at a temperature of 120–140 °C (250–280 °F) and a pressure of 0.3–0.5 MPa (45–75 psi).
=== Enzyme regulation === The activity of some enzymes is regulated by ADP-ribosylation. For instance, the activity of Rodospirillum rubrum di-nitrogenase-reductase is turned off by ADP-ribosylation of an arginine residue, and reactivated by the removal of the ADP-ribosyl group.
=== Special populations === It is recommended that women with active tuberculosis who are pregnant or breastfeeding take isoniazid. Preventive therapy should be delayed until after giving birth. Nursing mothers excrete a relatively low and non-toxic concentration of INH in breast milk, and their babies are at low risk for side effects. Both pregnant women and infants being breastfed by mothers taking INH should take vitamin B6 in its pyridoxine form to minimize the risk of peripheral nerve damage. Vitamin B6 is used to prevent isoniazid-induced B6 deficiency and neuropathy in people with a risk factor, such as pregnancy, lactation, HIV infection, alcoholism, diabetes, kidney failure, or malnutrition. People with liver dysfunction are at a higher risk for hepatitis caused by INH, and may need a lower dose. Levels of liver enzymes in the bloodstream should be frequently checked in daily alcohol drinkers, pregnant women, IV drug users, people over 35, and those who have chronic liver disease, severe kidney dysfunction, peripheral neuropathy, or HIV infection since they are more likely to develop hepatitis from INH.
==== Diabetes ==== A meta-analysis reported that vitamin D supplementation significantly reduced the risk of type 2 diabetes for non-obese people with prediabetes. Another meta-analysis reported that vitamin D supplementation significantly improved glycemic control [homeostatic model assessment-insulin resistance (HOMA-IR)], hemoglobin A1C (HbA1C), and fasting blood glucose (FBG) in individuals with type 2 diabetes. In prospective studies, high versus low levels of vitamin D were respectively associated with a significant decrease in risk of type 2 diabetes, combined type 2 diabetes and prediabetes, and prediabetes. A systematic review included one clinical trial that showed vitamin D supplementation together with insulin maintained levels of fasting C-peptide after 12 months better than insulin alone.
Sources: en.wikipedia.org
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.
It blocks the amino-terminal degradation step that limits native GHRH. The addition extends how long the peptide survives in plasma without removing its ability to activate the receptor.
The chain contains 44 amino acid residues. It matches the human GHRH(1-44) sequence apart from the amino-terminal modification.
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.